摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

Cyclohexylsulfamate | 7540-60-5

中文名称
——
中文别名
——
英文名称
Cyclohexylsulfamate
英文别名
N-cyclohexylsulfamate
Cyclohexylsulfamate化学式
CAS
7540-60-5
化学式
C6H12NO3S-
mdl
——
分子量
178.23
InChiKey
HCAJEUSONLESMK-UHFFFAOYSA-M
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

计算性质

  • 辛醇/水分配系数(LogP):
    0.6
  • 重原子数:
    11
  • 可旋转键数:
    1
  • 环数:
    1.0
  • sp3杂化的碳原子比例:
    1.0
  • 拓扑面积:
    77.6
  • 氢给体数:
    1
  • 氢受体数:
    4

反应信息

  • 作为反应物:
    参考文献:
    名称:
    甜蜜素氨基磺酸酶的部分纯化和某些性质。
    摘要:
    从假非诺斯菌(Pseudotnonas sp.)的提取物中部分纯化了620倍的酶;该酶催化以下反应:环己基氨基磺酸盐+H2O→环己胺+SO42−+H+。反应的最佳pH值在6.5和6.7之间。环己基氨基磺酸盐酶的Km值为5×lO−3M。该酶具有相对较高的热稳定性,在含有0.1%明胶的Tris-HCl中,酶可在-20°C下保存至少3个月,活性仅损失10%。该酶专一水解氨基磺酸盐,优先水解三至八碳脂肪族氨基磺酸盐。二正丙胺和N-甲基环己胺等仲胺的氨基磺酸盐几乎不被水解。磺胺、氨基磺酸盐(NH2SO3−)和环己基硫酸盐不被水解。EDTA会导致活性完全丧失,但加入各种金属离子可部分恢复活性。在EDTA抑制作用的逆转方面,未观察到金属离子的特异性。Hg2+、Cd2+和碘乙酸表现出强烈的抑制作用,但PCMB的抑制作用并不像预期的那样强。还描述了其他各种阳离子和阴离子对酶活性的影响。
    DOI:
    10.1093/oxfordjournals.jbchem.a130407
  • 作为产物:
    描述:
    (Z)-2-Acetylamino-3-(4-oxiranylmethoxy-phenyl)-acrylic acid methyl ester 、 异丙胺环拉酸乙醚 在 crude base 、 乙酸乙酯盐酸Sodium sulfate-III 作用下, 以 四氢呋喃丙酮 为溶剂, 反应 18.0h, 以the N-cyclohexylsulphamate of 1-[p-(2-acetylamino-2-carbomethoxy-vinyl)-phenoxy]-2-hydroxy-3-isoproylamino-propane, melting point 121°-125°C, is obtained的产率得到Cyclohexylsulfamate
    参考文献:
    名称:
    Amines and processes for their manufacture
    摘要:
    式为##STR1##的胺,其中R.sub.1是低烷基,低烷氧基或氨基,R.sub.2是氢或低烷基,R.sub.3是氢,低烷基,羧基或低烷氧羰基,R.sub.4是氢或低烷基,R.sub.5是低烷基,芳基-低烷基或可选功能修饰的羧基-低烷基,R.sub.6表示卤素,三氟甲基,低烷基,低烯基,低烷氧基,低烯基氧基,硝基,低烷氧甲基,氨基甲酰,N-低烷基氨基甲酰,腈,低炔氧基或氢,及其盐可阻塞心脏和血管的β-受体,适用于治疗心律失常和心绞痛,并作为中间体,特别是用于药物活性物质。
    公开号:
    US04038414A1
点击查看最新优质反应信息

文献信息

  • N-cinnamylcarbamic acid esters
    申请人:Ciba-Geigy Corporation
    公开号:US04014920A1
    公开(公告)日:1977-03-29
    Amines of the formula ##SPC1## Wherein R.sub.1 is lower alkyl, lower alkoxy or amino, R.sub.2 is hydrogen or lower alkyl, R.sub.3 is hydrogen, lower alkyl, carboxyl or lower alkoxycarbonyl, R.sub.4 is hydrogen or lower alkyl, R.sub.5 is lower alkyl, aryl-lower alkyl or optionally functionally modified carboxy-lower alkyl and R.sub.6 denotes halogen, trifluoromethyl, lower alkyl, lower alkenyl, lower alkoxy, lower alkenyloxy, nitro, lower alkoxymethyl, carbamoyl, N-lower alkylcarbamoyl, nitrile, lower alkinyloxy or hydrogen, and their salts block cardiac and vascular .beta.-receptors the are useful in the treatment of arrhythenias and angina pectoris and as intermediates for, especially for pharmaceutically active substances.
    化合物的胺式##SPC1##其中R.sub.1是低烷基,低烷氧基或氨基,R.sub.2是氢或低烷基,R.sub.3是氢,低烷基,羧基或低烷氧羰基,R.sub.4是氢或低烷基,R.sub.5是低烷基,芳基-低烷基或可选择性功能修饰的羧基-低烷基,R.sub.6表示卤素,三氟甲基,低烷基,低烯基,低烷氧基,低烯基氧基,硝基,低烷氧甲基,氨基甲酰,N-低烷基氨基甲酰,腈,低炔氧基或氢,并且它们的盐可以阻断心脏和血管的β-受体,对于治疗心律失常和心绞痛以及作为特别是药物活性物质的中间体是有用的。
  • Amines and processes for their manufacture
    申请人:Ciba-Geigy Corporation
    公开号:US04038414A1
    公开(公告)日:1977-07-26
    Amines of the formula ##STR1## wherein R.sub.1 is lower alkyl, lower alkoxy or amino, R.sub.2 is hydrogen or lower alkyl, R.sub.3 is hydrogen, lower alkyl, carboxyl or lower alkoxycarbonyl, R.sub.4 is hydrogen or lower alkyl, R.sub.5 is lower alkyl, aryl-lower alkyl or optionally functionally modified carboxy-lower alkyl and R.sub.6 denotes halogen, trifluoromethyl, lower alkyl, lower alkenyl, lower alkoxy, lower alkenyloxy, nitro, lower alkoxymethyl, carbamoyl, N-lower alkylcarbamoyl, nitrile, lower alkinyloxy or hydrogen, and their salts block cardiac and vascular .beta.-receptors the are useful in the treatment of arrhythenias and angina pectoris and as intermediates for, especially for pharmaceutically active substances.
    式为##STR1##的胺,其中R.sub.1是低烷基,低烷氧基或氨基,R.sub.2是氢或低烷基,R.sub.3是氢,低烷基,羧基或低烷氧羰基,R.sub.4是氢或低烷基,R.sub.5是低烷基,芳基-低烷基或可选功能修饰的羧基-低烷基,R.sub.6表示卤素,三氟甲基,低烷基,低烯基,低烷氧基,低烯基氧基,硝基,低烷氧甲基,氨基甲酰,N-低烷基氨基甲酰,腈,低炔氧基或氢,及其盐可阻塞心脏和血管的β-受体,适用于治疗心律失常和心绞痛,并作为中间体,特别是用于药物活性物质。
  • Partial Purification and Some Properties of Cyclamate Sulfamatase*
    作者:Toshio NIIMURA、Toshie TOKIEDA、Tsutomu YAMAHA
    DOI:10.1093/oxfordjournals.jbchem.a130407
    日期:1974.2
    An enzyme was partially purified 620-fold from extracts of Pseudotnonas sp.; it catalyzes the following reaction:cyclohexylsulfamate+H2O → cyclohexylamine+SO42−+H+.The pH optimum of the reaction was between 6.5 and 6.7. The Km value of the enzyme for cyclamate was 5×lO−3M. The enzyme was comparatively heat-stable, and the enzyme could be stored at −20°C in Tris-HCl containing 0.1% gel-atin for at least 3 months with only 10% loss of activity.The enzyme was found to be specific for the hydrolysis of sulfamates, and it hydrolyzed aliphatic sulfamates with three to eight carbons preferentially. The sulfamates of secondary amines such di-n-propylamine and N-methylcyclohexylamine were scarcely hydrolyzed. Sulfanilamide, sulfamate(NH2SO3−), and cyclohexyl sulfate were not hydrolyzed.EDTA caused complete loss of activity, which could be partially restored by the addition of various metal ions. No metal ion specificity was observed as regards the reversal of EDTA inhibition.Hg2+, Cd2+, and iodoacetic acid showed strong inhibitory effects, but PCMB did not show as strong an inhibition as expected. The effects of various other cations and anions on the enzyme activity are also described.
    从假非诺斯菌(Pseudotnonas sp.)的提取物中部分纯化了620倍的酶;该酶催化以下反应:环己基氨基磺酸盐+H2O→环己胺+SO42−+H+。反应的最佳pH值在6.5和6.7之间。环己基氨基磺酸盐酶的Km值为5×lO−3M。该酶具有相对较高的热稳定性,在含有0.1%明胶的Tris-HCl中,酶可在-20°C下保存至少3个月,活性仅损失10%。该酶专一水解氨基磺酸盐,优先水解三至八碳脂肪族氨基磺酸盐。二正丙胺和N-甲基环己胺等仲胺的氨基磺酸盐几乎不被水解。磺胺、氨基磺酸盐(NH2SO3−)和环己基硫酸盐不被水解。EDTA会导致活性完全丧失,但加入各种金属离子可部分恢复活性。在EDTA抑制作用的逆转方面,未观察到金属离子的特异性。Hg2+、Cd2+和碘乙酸表现出强烈的抑制作用,但PCMB的抑制作用并不像预期的那样强。还描述了其他各种阳离子和阴离子对酶活性的影响。
查看更多

表征谱图

  • 氢谱
    1HNMR
  • 质谱
    MS
  • 碳谱
    13CNMR
  • 红外
    IR
  • 拉曼
    Raman
查看更多图谱数据,请前往“摩熵化学”平台
查看更多图谱数据,请前往“摩熵化学”平台
cnmr
查看更多图谱数据,请前往“摩熵化学”平台
查看更多图谱数据,请前往“摩熵化学”平台
  • 峰位数据
  • 峰位匹配
  • 表征信息
Shift(ppm)
Intensity
查看更多图谱数据,请前往“摩熵化学”平台
Assign
Shift(ppm)
查看更多图谱数据,请前往“摩熵化学”平台
测试频率
样品用量
溶剂
溶剂用量
查看更多图谱数据,请前往“摩熵化学”平台

同类化合物

甜蜜素 环拉酸 异米尼尔环璜酸盐 二环己基氨基磺酸 4-[(2S)-2-氨基-4-(甲基硫烷基)丁酰]-L-α-谷氨酰-3-(4H-咪唑-4-基)-L-丙氨酰-L-苯丙氨酸 4-(二甲基氨基)-2-异丙基-2-苯基戊腈环璜酸盐 5-methyl-2-(1-methylethyl)cyclohexyl (3aR,7aS)-rel-hexahydro-1,2,3-benzothiazole-3(3aH)-carboxylate 2,2-dioxide 5-methyl-2-(1-methylethyl)cyclohexyl (3aR,7aS)-rel-hexahydro-1,2,3-benzothiazole-3(3aH)-carboxylate 2,2-dioxide [(1R,2S,5R)-5-methyl-2-propan-2-ylcyclohexyl] 2,2-dioxo-3a,4,5,6,7,7a-hexahydrobenzo[d]oxathiazole-3-carboxylate 5,6-dihydro-1'-(2-thienyl-methyl)spiro[imidazo[2,1-b][3]benzazepine-11-[11H],4'-piperidine] cyclohexylsulfamate (1:1) 2,2,2-trichloroethyl cyclohexylsulfamate [Bi(CycH)3] (-)-3,18-(2,2-dioxido-1,2,3-oxathiazinan-3-yl)-13-methyl-17-norkauran-16-one ethylmethyl-5-(tetrahydro-2-furanyl)pentylsulfonium cyclohexylsulfamate Phenylephrine cyclohexylsulfamate Magnesium cyclamate Silver cyclamate Sulfamic acid, (3-methylcyclohexyl)- 2-(p-Methoxy-alpha-(1-piperidyl)benzyl)cyclohexanol cyclohexanesulfamate Barium cyclohexanesulfamate Butyranilide, 2'-ethyl-3-(2-methoxyethyl)amino-3-methyl-, cyclohexane sulfamate 1-(4-Cyclopropyl-phenyl)-2-methylamino-ethanol; compound with cyclohexyl-sulfamic acid Cyclohexylsulfamic acid--3-(1-butylpyrrolidin-2-yl)-1H-indole (1/1) Cyclohexylsulfamic acid--1-benzyl-3-(1-methylpyrrolidin-2-yl)-1H-indole (1/1) (+)-Furfurylmethyl(alpha-methylphenethyl)ammonium cyclohexylsulphamate Cyclamate magnesium dihydrate potassium cyclohexylsulfamate Cyclohexylsulfamic acid--1-(4-chlorophenyl)-N-[(furan-2-yl)methyl]-N-methylpropan-2-amine (1/1) Cyclohexylsulfamic acid--N-[(furan-2-yl)methyl]-N-methyl-1-[3-(trifluoromethyl)phenyl]propan-2-amine (1/1) Calcium cyclamate N-Nitrosocyclohexylsulfamic acid 3,4,5,6-tetrahydro-6-methyl-3-benzylspiro[1,2,3-oxathiazine-2,2-dioxide-4-cyclohexane] (R)-1,1,1-Trichloro-4-(hex-5-yn-1-ylamino)-4-oxobutan-2-yl (5R,8R)-8-methyl-4-methylene-7-oxo-2-azabicyclo[3.3.1]nonane-2-sulfonate ethanol-cyclam (2S,3R)-2,3-dihydroxy-3-phenyl-1-[(1S,2R,6S,7R)-7,10,10-trimethyl-4,4-dioxo-3-oxa-4lambda6-thia-5-azatricyclo[5.2.1.02,6]decan-5-yl]propan-1-one (2S)-2,3-dihydroxy-1-[(1S,2R,6S,7R)-7,10,10-trimethyl-4,4-dioxo-3-oxa-4lambda6-thia-5-azatricyclo[5.2.1.02,6]decan-5-yl]propan-1-one 2,2,2-Trichloroethyl 2,2-dioxo-3-oxa-2lambda6-thia-1,4-diazaspiro[5.5]undecane-4-carboxylate (2S,3R)-3-cyclohexyl-2,3-dihydroxy-1-[(1S,2R,6S,7R)-7,10,10-trimethyl-4,4-dioxo-3-oxa-4lambda6-thia-5-azatricyclo[5.2.1.02,6]decan-5-yl]propan-1-one Sodium dicyclohexylsulfamate Sodium N-ethylcyclohexylsulfamate Barium(2+);cyclohexylsulfamic acid 2,2,2-Trichloroethyl 7-azabicyclo[4.1.0]heptane-7-sulfonate (2-oxo-cyclohexyl)sulfamic acid 2,2,2-trichloroethyl ester [(1S,2R,5S,7S,10S,11S,13R,17S,20R)-10,20-dimethyl-15,15-dioxo-16-oxa-15lambda6-thia-14-azapentacyclo[11.6.1.02,11.05,10.017,20]icosan-7-yl]oxy-tri(propan-2-yl)silane methyl 1-benzyl-3-pyrrolidineacetate cyclohexylsulfamate 2,2,2-Trichloroethyl 3-azatricyclo[3.2.1.02,4]octane-3-sulfonate [(2R)-3-carboxy-2-hydroxypropyl]-trimethylazanium;N-cyclohexylsulfamate azane;cyclohexylsulfamic acid (1,2,3-Trimethylcyclohexyl)sulfamic acid Beta-diethylaminoethyl-p-aminobenzoate cyclohexylsulfamate